APA

Dhingra M. S., Rao R., Bhat S., Joshi R., Kalra V., Parikh H. R., Rao S. N., Sethi G. R., Shah N. & Muzaffaruddin M. (20110620). Evaluation of the immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Shan 4) with EasyFourTM in Indian infants administered per EPI schedule: a phase III trial. : Human vaccines.

Chicago

Dhingra Mandeep S, Rao Raman, Bhat Swarnarekha, Joshi Rajan, Kalra Veena, Parikh Harish R, Rao S Narasimha, Sethi G R, Shah Nitin and Muzaffaruddin M. 20110620. Evaluation of the immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Shan 4) with EasyFourTM in Indian infants administered per EPI schedule: a phase III trial. : Human vaccines.

Harvard

Dhingra M. S., Rao R., Bhat S., Joshi R., Kalra V., Parikh H. R., Rao S. N., Sethi G. R., Shah N. and Muzaffaruddin M. (20110620). Evaluation of the immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Shan 4) with EasyFourTM in Indian infants administered per EPI schedule: a phase III trial. : Human vaccines.

MLA

Dhingra Mandeep S, Rao Raman, Bhat Swarnarekha, Joshi Rajan, Kalra Veena, Parikh Harish R, Rao S Narasimha, Sethi G R, Shah Nitin and Muzaffaruddin M. Evaluation of the immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Shan 4) with EasyFourTM in Indian infants administered per EPI schedule: a phase III trial. : Human vaccines. 20110620.